Credit: CC0 Public Domain Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published
Study design and flowchart. Type 2 diabetes. Credit: Diabetes, Obesity and Metabolism (2024). DOI: 10.1111/dom.15840 A pioneering clinical trial conducted at Sheba Medical Center, Tel Hashomer, and Ben-Gurion University of
Weighted Cumulative Incidence for Suicide Death Among Users of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Sweden and Denmark. Credit: JAMA Internal Medicine (2024). DOI: 10.1001/jamainternmed.2024.4369
Credit: Unsplash/CC0 Public Domain New research published in New England Journal of Medicine and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD)
Credit: Pixabay/CC0 Public Domain A series of case reports to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD), held in Madrid (9–13
Pancreatic islets from adult mice. On the left, islet composed of different types of endocrine cells. Right: pancreatic islet composed solely of beta cells. Credit: Laboratoire Pedro Herrera – UNIGE
Credit: ACS Pharmacology & Translational Science (2024). DOI: 10.1021/acsptsci.4c00418 People with chronic diabetic foot ulcers could soon have a new way to treat their wounds for faster healing and fewer
Credit: CC0 Public Domain The global trend towards low-carbohydrate, high-fat diets for weight loss can in fact increase a person’s risk of developing diabetes by a staggering 20%, according to
